1.Are Your Kidneys Ok? Detect early to protect kidney health
Joseph A VASSALOTTI ; Anna FRANCIS ; Augusto Cesar Soares DOS SANTOS JR ; Ricardo CORREA-ROTTER ; Dina ABDELLATIF ; Li-Li HSIAO ; Stefanos ROUMELIOTIS ; Agnes HARIS ; Latha A KUMARASWAMI ; Siu-Fai LUI ; Alessandro BALDUCCI ; Vassilios LIAKOPOULOS
Brunei International Medical Journal 2025;21():25-33
Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk and decrease mortality. We must ask “Are your kidneys ok?” using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. This World Kidney Day, we assert that case -finding in high-risk populations, or even population level screening, can decrease the burden of kidney disease globally. Early -stage CKD is asymptomatic, simple to test for and recent paradigm shifting CKD treatments such as sodium glucose co-transporter -2 inhibitors dramatically improve outcomes and favour the cost -benefit analysis for screening or case -finding programmes. Despite this, numerous barriers exist, including resource allocation, healthcare funding, healthcare infrastructure and healthcare -professional and population awareness of kidney disease. Coordinated efforts by major kidney non -governmental organisations to prioritise the kidney health agenda for governments and aligning early detection efforts with other current programmes will maximise efficiencies.
2.MIND THE GAP IN KIDNEY CARE: TRANSLATING WHAT WE KNOW INTO WHAT WE DO
Valerie A. LUCYKX ; Katherine R. TUTTLE ; Dina ABDELLATIF ; Ricardo CORREA-ROTTER ; Winston W.S. FUNG ; Agnes Haris ; Li-Li HSIAO ; Makram KHALIFE ; Latha A. KUMARASWAMI ; Fiona LOUD ; Vasundhara RAGHAYAN ; Stefanos ROUMELIOTIS ; Marianella SIERRA ; Ifeoma ULASI ; Bill WANG ; Siu-Fai LUI ; Vassilios LIAKOPOULOS ; Alessandro BALDUCCI
Brunei International Medical Journal 2024;20():29-43
Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions worldwide are diagnosed, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because in the early stages it is often silent. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from patient to clinician to health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay.

Result Analysis
Print
Save
E-mail